IMCR — IMMUNOCORE HLDGS PLC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About IMMUNOCORE HLDGS PLC (IMCR)
IMMUNOCORE HLDGS PLC (IMCR) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $37M. Across recent filings, tracked investors recorded 1 new positions, 1 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in IMCR
How many top investors track IMCR
A small number of top investors own this.
IMCR Ownership Composition
How IMMUNOCORE HLDGS PLC is held across tracked investor types, based on reported 13F positions.
- Other57.6%
- Hedge Funds42.4%
Tracked investors reporting IMCR
- Izzy EnglanderMar 31, 2026Millennium ManagementShares1.2MValue$37.3M% Portfolio0.02%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares1.1MValue$33.2M% Portfolio0.04%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares240.3KValue$7.2M% Portfolio0.00%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares18.9KValue$570.7K% Portfolio0.00%
Recent activity
- Increased$570.7K(90.21%)May 15, 2026
- New$345.4KFeb 13, 2026
Frequently asked questions
- How many institutional investors hold IMCR?
- 4 tracked institutional investors disclosed a position in IMCR (IMMUNOCORE HLDGS PLC) in their most recent 13F filing.
- Who is the largest institutional holder of IMCR?
- Izzy Englander, Millennium Management, holds the largest disclosed position in IMCR, valued at $37M.
- Did institutional ownership of IMCR increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 1 increased, 0 reduced, and 0 fully exited IMCR.
- Where does this IMCR ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.